DGX - Lisata to use Haystack technology to evaluate pancreatic cancer asset certepetide
2024-07-18 11:27:06 ET
More on Quest Diagnostics, Lisata
- Quest Diagnostics: On A Quest For Growth
- Lisata Therapeutics, Inc. (LSTA) Q1 2024 Earnings Call Transcript
- Lisata Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
- Citi upgrades Illumina, Quest, Agilent to buy, downgrades Avantor
- Quest Diagnostics to acquire certain assets from OhioHealth